Skip to content

Clinical Study of Tongmai Yangxin Pill in Treating Slow Arrhythmia (Qi-Yin Deficiency Syndrome)

Clinical Study of Tongmai Yangxin Pill in Treating Slow Arrhythmia (Qi-Yin Deficiency Syndrome)

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900025781
Enrollment
Unknown
Registered
2019-09-07
Start date
2019-10-01
Completion date
Unknown
Last updated
2019-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Slow arrhythmia

Interventions

Sponsors

The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. It meets the diagnostic criteria of TCM palpitations of qi Yin deficiency syndrome and western medicine sinus bradycardia, atrioventricular block and pathological sinus atrial node syndrome. (1) sinus bradycardia: 24-hour dynamic ecg average heart rate < 60 times/min, 24h total heart rate < 86400 times; (2) sick sinus syndrome; (3) atrioventricular block; (4) occasional sinus arrestThose who do not meet the pacemaker standard or refuse to install pacemaker and have no history of fainting and amaurosia. 2. Aged from 35 to 75 years, regardless of gender. 3. Voluntarily participate in this study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with severe primary diseases of cerebrovascular, liver, kidney and hematopoietic system and severe cardiopulmonary insufficiency; Severe anemia, hypothyroidism, electrolyte disorder and drug - induced chronic arrhythmia patients. 2. Congenital heart disease, severe angina pectoris, acute stage of myocardial infarction, acute stage of middle or severe viral myocarditis and hypertensive crisis. 3. Sinus bradycardia with short paroxysmal atrial fibrillation, atrial flutter, supraventricular tachycardia. 4. Women who are pregnant, preparing for pregnancy or lactation and who are allergic to this drug.

Design outcomes

Primary

MeasureTime frame
Dynamic electrocardiogram;Electrocardiogram;Clinical symptoms and changes of tongue and pulse;

Countries

China

Contacts

Public ContactYingqiang Zhao

The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine

zhaoyingqiang1000@126.com+86 022-60637136

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026